Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Inflammation01:38

Inflammation

46.6K
Overview
46.6K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

659
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.

Diabetes & metabolism·2020
Same author

Heparin-binding EGF-like growth factor (HB-EGF) antisense oligonucleotide protected against hyperlipidemia-associated atherosclerosis.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Heritability of periodontal bone loss in mice.

Journal of periodontal research·2015
Same author

Zbtb16 has a role in brown adipocyte bioenergetics.

Nutrition & diabetes·2013
Same author

The mouse model for atherosclerosis.

Trends in cardiovascular medicine·2011
Same journal

Daily briefing: 'Cyborg' cockroaches breathe underwater with printed suit.

Nature·2026
Same journal

China boosts prestigious grants for young scientists - will it ease competition?

Nature·2026
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
関連記事をすべて見る

関連する実験動画

Updated: May 5, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 8, 2013

14.0K

動脈硬化症 (Atherosclerosis) とは 動脈硬化症 (Atherosclerosis) とは 動脈硬化症 (Atherosclerosis) とは

A J Lusis1

  • 1Department of Medicine, Biology Institute, University of California, Los Angeles 90095, USA. jlusis@mednet.ucla.edu

Nature
|September 23, 2000
PubMed
まとめ
この要約は機械生成です。

心臓病や脳卒中の主な原因である動脈硬化症は,複雑な炎症性疾患である. 新しいツールは,コレステロールの代謝とリスク要因が,動脈硬化性プラークの形成にどのように寄与するかを明らかにしています.

さらに関連する動画

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

1.4K
Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

221

関連する実験動画

Last Updated: May 5, 2026

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus
06:43

Quantitative Analysis and Characterization of Atherosclerotic Lesions in the Murine Aortic Sinus

Published on: December 8, 2013

14.0K
Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
09:55

Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis

Published on: October 25, 2024

1.4K
Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

221

科学分野:

  • 心血管科学 心血管科学
  • 病理学 パトロジー
  • 分子生物学は分子生物学である.

背景:

  • 動脈硬化症は,世界的に主要な死因であり,西洋化社会における全死亡の約50%を担っています.
  • それは,多数の環境的および遺伝的リスク要因を持つ複雑な病気であり,その細胞および分子機構を定義することは困難です.
  • 歴史的に老化の変性的なプロセスとして見られているが,最近の研究では,動脈硬化症を慢性炎症状態として再定義している.

研究 の 目的:

  • 動脈硬化症の基礎となる分子メカニズムを解明する.
  • コレステロール代謝の変化,その他のリスク要因,動脈硬化性プラーク形成との関連を理解する.
  • 動脈硬化症を老化の単純な結果と区別し,炎症性疾患として特徴づけること.

主な方法:

  • 遺伝子組み換えマウスモデルを使用して,疾患の進行を研究した.
  • 細胞および分子相互作用を分析するために新しい調査ツールを適用しました.
  • 危険因子に関する疫学研究から得られた統合された結果.

主要な成果:

  • コレステロール代謝と動脈硬化性プラークの危険因子を結びつける重要な分子機構を特定しました.
  • 動脈硬化症は慢性炎症疾患であり,退行的な老化プロセスだけではないことを実証しました.
  • プラークの破裂と血栓形成が急性臨床イベントを早める可能性があることが判明しました.

結論:

  • 動脈硬化症は,相互に関連した危険因子と代謝変化によって引き起こされる複雑な炎症性疾患です.
  • 先進的な調査ツール,特にマウスモデルにより,動脈硬化性プラーク発達の理解が著しく改善されました.
  • 動脈硬化症は,変性的な見方から,炎症性であり潜在的に急性である性質を認識する見方へのパラダイムシフトを必要とします.